understanding her2 alterations in advanced non-squamous nsclc
Published 2 years ago • 322 plays • Length 57:49Download video MP4
Download video MP3
Similar videos
-
1:20
understanding her2 alterations in advanced non-squamous non-small cell lung cancer| pathology hub
-
2:45
therapeutic advances in targeting her2 alterations in nsclc & remaining challenges
-
1:30:06
moving toward expanded precision treatment of her2- or her3-driven breast, gi, lung & other cancers
-
58:30
the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc
-
1:40
safety and anti-tumor activity of bay 2927088 in patients with her2-mutant nsclc
-
1:13
challenges to targeting her2 in lung cancer
-
6:31
gracecast - treatment options for patients with advanced nsclc and a her2- erbb2 mutation
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
33:28
novel targeted therapies for nsclc: exploring her2 dysregulation
-
0:31
remaining questions regarding her2-low breast cancer
-
1:26:11
the role of antibody drug conjugates in advanced non-small cell lung cancer
-
1:45
strategies to target her2 in lung cancer
-
1:06
immunotherapy combination in her2-positive breast cancer
-
4:23
evolution of targeted therapy in advanced nsclc
-
2:54
her2 mutation positive nsclc
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
1:01:45
enabling precision oncology care through collaboration